Alzai Health Corp. (TSXV:ALZI)

Market Cap	20.09M
Revenue (ttm)	69.09K
Net Income	-4.13M
EPS	-0.08
Shares Out	64.80M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	0.3100
Day's Range	n/a
52-Week Range	0.2750 - 0.5000
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 26, 2026

About Alzai Health

Alzai Health Corp., a healthcare technology company, provides artificial intelligence driven solution for risk screening. The company offers risk screening solutions for Mild Alzheimer’s Disease and Mild Cognitive Impairment. It caters to various markets including healthcare providers and payors, pharmaceutical companies, research organizations, and research sites, clinical trials and research companies, and public health and private payors. The company was incorporated in 2024 and is based in Toronto, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2024
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: ALZI

Financial Performance

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Oct 9, 2026

Data Sources Report a data error